Amsterdam-based VC OTB Ventures secures €170M to invest in European deep tech startups
Amsterdam-based OTB Ventures, a European VC focused on DeepTech, announced on Thursday that it has closed its second fund at $185M (approximately €170M).
Popular topics
Venture capital — fund formation, deal flow, the institutional incentives that govern where money goes, and the founder relationships that move it.
456 articles · Venture Capital
Amsterdam-based OTB Ventures, a European VC focused on DeepTech, announced on Thursday that it has closed its second fund at $185M (approximately €170M).
UK-based Mercia Ventures, an active venture capital investor, on Wednesday, announced the completion of a £60M (approximately €70.1M) fundraising by the three Northern Venture Capital Trusts, an integral part of Mercia's third-party funds under Management.
London-based Ada Ventures, an inclusive venture firm, has announced the final close of a £63M (approximately €73.83M) fund, the second fund from the firm, to support a diverse group of early-stage founders.
UK-based Grwth, a company specialised in matchmaking services and strategic growth advisory, on Monday, announced the launch of its consumer venture fund -- Grwth Ventures, marking a significant addition to the Grwth family.
Showpad’s former CEO Pieterjan Bouten announces the launch of Entourage, a $30M (approximately €27.72M) Venture Studio and early-stage venture capital fund to support the next wave of European SaaS founders.
Amsterdam-based FounderFuel, a community for founders and investors, announced the launch of its new investment fund.
Oslo-based Verdane, a European specialist growth investment firm, on Monday announced the successful final close of Verdane Edda III (“Edda…
US-based Horizon Capital, a private equity firm, announced on Friday, February 23, the successful closing of its latest Ukraine-focused…
Amsterdam-based Orient Growth Ventures, an investment firm, announced on Thursday that it has announced the closing of its second…
London-based VC firm Episode 1 has closed a £76M (nearly €88.72M) early-stage fund, including a £20M (nearly €23.34M) cornerstone commitment from British Patient Capital and the National Security Strategic Investment Fund.
Seroba, a Dublin-based life sciences venture capital firm, has closed its Seroba Fund IV at €123M.
Vienna-based venture capital firm Speedinvest has closed its fourth flagship fund, Speedinvest 4 (Si4), at €350M, an additional €50M above target.